Review
Open access
Sep 2026
Combination Immunotherapy in Pancreatic Cancer: Current Clinical Evidence and Mechanistic Rationale for Overcoming a “Cold” Tumor
Simple Summary Pancreatic cancer usually responds poorly to drugs that release the brakes on immune cells. Combining these drugs with other treatments may help, but early responses do not show which treatment contributed or whether patients live longer. This review examines clinical studies alongside four interacting p...
Bode T. Eisenmenger, Abraham S. Rappaport, Liam H. Connell et al.
· Cancers · 0 citations